FibroBiologics, Inc. Common Stock
USD1.05
-0.07 (-6.25%)
CEO
Peter O'Heeron
IPO Date
2024-02-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.13
Prev. Close
$1.12
Day Low
$1.05
Day High
$1.13
52W Low
$0.95
52W High
$19.80
Market Cap
$0.00B
Volume
0.10M
| 61,607 |
| $1.38 |
| 4 May 2026 | Davis Jason | Chief Financial Officer | A-Award | Acquired | 61,607 | $1.38 |
| 4 May 2026 | GARCIA RUBEN A | General Counsel | A-Award | Acquired | 61,607 | $1.38 |
| 5 Mar 2026 | Khoja Hamid | Chief Scientific Officer | P-Purchase | Acquired | 30,000 | $0.38 |
| 4 Mar 2026 | O'HEERON PETE | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 18,200 | $0.41 |
| 4 Mar 2026 | O'HEERON PETE | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 17,428 | $0.35 |
| 4 Mar 2026 | O'HEERON PETE | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 15,872 | $0.38 |
| 3 Mar 2026 | Davis Jason | Chief Financial Officer | P-Purchase | Acquired | 70,000 | $0.41 |
| 2 Mar 2026 | GARCIA RUBEN A | General Counsel | P-Purchase | Acquired | 40,000 | $0.33 |